chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Muscle swelling, Pyrexia
Clinical narrative: SWEATING; LEG WARM TO TOUCH; MUSCLE BULGING DUE TO THE CONTRACTIONS; FREEZING; ON AND OFF HEADACHE; FEVER; SEVERE LEFT LEG CRAMP; This spontaneous report received from a consumer concerned a 43 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: leg cramps. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 13-AUG-2021, the patient experienced severe left leg cramp. On 14-AUG-2021, the patient experienced sweating. On 14-AUG-2021, the patient experienced freezing. On 14-AUG-2021, the patient experienced leg warm to touch. On 14-AUG-2021, the patient experienced muscle bulging due to the contractions. On 14-AUG-2021, the patient experienced on and off headache. On 14-AUG-2021, the patient experienced fever. Laboratory data included: Body temperature (NR: not provided) 102.1 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, severe left leg cramp, sweating, freezing, leg warm to touch, on and off headache, and muscle bulging due to the contractions. This report was non-serious.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dysgeusia, Fatigue
Clinical narrative: BRUISE ON RIGHT FOREARM; TIREDNESS; SENSATION OF TONGUE COATED IN SALT; This spontaneous report received from a patient concerned a 64 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: pollen allergy, allergies nos, food allergy, alcoholic, and non smoker, and other pre-existing medical conditions included: No medical disorder. Patient reported no drug abuse or illicit usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. Concomitant medications included ascorbic acid, and calcium/colecalciferol. On 30-JUL-2021, the patient experienced sensation of tongue coated in salt. On 31-JUL-2021, the patient experienced tiredness. On AUG-2021, the patient experienced bruise on right forearm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tiredness on 31-JUL-2021, and had not recovered from bruise on right forearm, and sensation of tongue coated in salt. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE WITH A PAIN SCALE OF 5/10; This spontaneous report received from a parent concerned an 18 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A,  expiry: UNKNOWN) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. No concomitant medications were reported.  On 14-AUG-2021, the patient experienced headache with a pain scale of 5/10. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache with a pain scale of 5/10. This report was non-serious.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Neurological examination
Clinical narrative: PERSISTENT NUMBNESS IN RIGHT FOOT; This spontaneous report received from a physician concerned a 51 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-SEP-2021) dose was not reported, administered on 13-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, Laboratory data included: Neurological examination (NR: not provided) Decreased sensation on right foot compared to the other one. On 13-AUG-2021, the patient experienced persistent numbness in right foot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from persistent numbness in right foot. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Injection site bruising, Nausea, Pain in extremity
Clinical narrative: WORSENING SINUS SYMPTOMS WITH RUNNY NOSE/ SEVERE HEADACHE AROUND SINUSES AND TEMPLES; ITCHY ARMS; COUGHING UP YELLOW; GREENISH-YELLOW COLOR BRUISE AT THE INJECTION SITE; WHOOSHING IN EARS; PAIN IN LEFT HAND ACROSS JOINTS OVER THE KNUCKLES; NAUSEA; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: sinus symptoms. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1820096, expiry: UNKNOWN) dose was not reported, administered on 06-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, the patient experienced worsening sinus symptoms with runny nose/ severe headache around sinuses and temples. On AUG-2021, the patient experienced itchy arms. On AUG-2021, the patient experienced coughing up yellow. On AUG-2021, the patient experienced greenish-yellow color bruise at the injection site. On AUG-2021, the patient experienced whooshing in ears. On AUG-2021, the patient experienced pain in left hand across joints over the knuckles. On AUG-2021, the patient experienced nausea. Treatment medications (dates unspecified) included: ibuprofen, sucralfate, acetylsalicylic acid/caffeine/paracetamol/salicylamide, and paracetamol. The action taken with covid-19 vaccine was not applicable. The patient recovered from itchy arms on AUG-2021, was recovering from nausea, and the outcome of coughing up yellow, pain in left hand across joints over the knuckles, worsening sinus symptoms with runny nose/ severe headache around sinuses and temples, whooshing in ears and greenish-yellow color bruise at the injection site was not reported. This report was non-serious. This case, from the same reporter is linked to 20210832299.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Tinnitus
Clinical narrative: WORSENING SINUS SYMPTOMS WITH RUNNY NOSE/ SEVERE HEADACHE AROUND SINUSES AND TEMPLES; ITCHY ARMS; COUGHING UP YELLOW; GREENISH-YELLOW COLOR BRUISE AT THE INJECTION SITE; WHOOSHING IN EARS; PAIN IN LEFT HAND ACROSS JOINTS OVER THE KNUCKLES; NAUSEA; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: sinus symptoms. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1820096, expiry: UNKNOWN) dose was not reported, administered on 06-AUG-2021 for prophylactic vaccination. No concomitant medications were reported. On AUG-2021, the patient experienced worsening sinus symptoms with runny nose/ severe headache around sinuses and temples. On AUG-2021, the patient experienced itchy arms. On AUG-2021, the patient experienced coughing up yellow. On AUG-2021, the patient experienced greenish-yellow color bruise at the injection site. On AUG-2021, the patient experienced whooshing in ears. On AUG-2021, the patient experienced pain in left hand across joints over the knuckles. On AUG-2021, the patient experienced nausea. Treatment medications (dates unspecified) included: ibuprofen, sucralfate, acetylsalicylic acid/caffeine/paracetamol/salicylamide, and paracetamol. The action taken with covid-19 vaccine was not applicable. The patient recovered from itchy arms on AUG-2021, was recovering from nausea, and the outcome of coughing up yellow, pain in left hand across joints over the knuckles, worsening sinus symptoms with runny nose/ severe headache around sinuses and temples, whooshing in ears and greenish-yellow color bruise at the injection site was not reported. This report was non-serious. This case, from the same reporter is linked to 20210832299.
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Disturbance in attention, Fatigue, Feeling abnormal, Paraesthesia
Clinical narrative: REGULAR REACTIONS; CANNOT CONCENTRATE; TINGLING IN FEET, MOVED UP THE LEGS, UPWARDS INTO THE FACE AND REST OF THE BODY; TIRED; BRAIN FOG; This spontaneous report received from a patient concerned a 56 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: cigarette smoker, and non-alcohol user, and other pre-existing medical conditions included: The patient had no known allergies, no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A and expiry: UNKNOWN) dose was not reported, administered on 29-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-AUG-2021, the patient experienced brain fog. On 12-AUG-2021, the patient experienced cannot concentrate. On 12-AUG-2021, the patient experienced tingling in feet, moved up the legs, upwards into the face and rest of the body. On 12-AUG-2021, the patient experienced tired. On an unspecified date, the patient experienced regular reactions. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from regular reactions, and had not recovered from tired, tingling in feet, moved up the legs, upwards into the face and rest of the body, brain fog, and cannot concentrate. This report was non-serious.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 32-year-old female patient (para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025T20-2A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use in August 2020. Concurrent medical conditions included Asthma since 2002. Concomitant products included LORATADINE for Allergy, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Pregnancy.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-May-2021. On 31-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The vaginal delivery occurred on 10-May-2021, which was reported as Full-term. For neonate 1, with an APGAR score of 8 and 9 at (1, 5 minutes). The outcome was reported as Delivered NOS. On 31-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Estimated date of conception- 4 Aug 2020 Patient delivered a female baby (weeks at gestation 39 weeks, weight (3.7 kgs), length (53.3 cms) and head circumference (33 cms).   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: Significant follow up appended to AER-updated pregnancy information and outcome.; Sender's Comments: This is a case of product exposure during pregnancy with no associated adverse events for this 32-year-old female patient. Patient will continue to be contacted for further monitoring of adverse events during the pregnancy.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure measurement, Electrocardiogram, Erythema, Flushing
Clinical narrative: anxiety; flushing; missed dose; red cheeks; swollen cheeks; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety), FLUSHING (flushing), ERYTHEMA (red cheeks), SWELLING FACE (swollen cheeks) and PRODUCT DOSE OMISSION ISSUE (missed dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Stenosis (spin,neck), Arthritis and Dermal filler injection. Concurrent medical conditions included Drug allergy (Bactrim, Ceclor,cipro,), Penicillin allergy, Tetanus immunisation, Coronary artery disease, Bee sting (Bees) and Hay fever. Concomitant products included ATORVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for Coronary artery disease, LISINOPRIL, METOPROLOL, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and PROBIOTICS NOS (PROBIOTICS) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (red cheeks) and SWELLING FACE (swollen cheeks). On an unknown date, the patient experienced ANXIETY (anxiety), FLUSHING (flushing) and PRODUCT DOSE OMISSION ISSUE (missed dose). On 23-Jan-2021, ERYTHEMA (red cheeks) and SWELLING FACE (swollen cheeks) had resolved. At the time of the report, ANXIETY (anxiety), FLUSHING (flushing) and PRODUCT DOSE OMISSION ISSUE (missed dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) pulse and B. P were elevated. On an unknown date, Electrocardiogram: normal normal (normal) normal. On an unknown date, Heart rate: increased (High) pulse and B. P were elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was received by the patient   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: significant follow up includes patient other relevant history and events added flushing and anxiety and lab data was added. On 02-Aug-2021: Non-Significant follow up appended On 02-Aug-2021: Non significant follow up patients image was added
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Product dose omission issue, Swelling face
Clinical narrative: anxiety; flushing; missed dose; red cheeks; swollen cheeks; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (anxiety), FLUSHING (flushing), ERYTHEMA (red cheeks), SWELLING FACE (swollen cheeks) and PRODUCT DOSE OMISSION ISSUE (missed dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Stenosis (spin,neck), Arthritis and Dermal filler injection. Concurrent medical conditions included Drug allergy (Bactrim, Ceclor,cipro,), Penicillin allergy, Tetanus immunisation, Coronary artery disease, Bee sting (Bees) and Hay fever. Concomitant products included ATORVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for Coronary artery disease, LISINOPRIL, METOPROLOL, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and PROBIOTICS NOS (PROBIOTICS) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced ERYTHEMA (red cheeks) and SWELLING FACE (swollen cheeks). On an unknown date, the patient experienced ANXIETY (anxiety), FLUSHING (flushing) and PRODUCT DOSE OMISSION ISSUE (missed dose). On 23-Jan-2021, ERYTHEMA (red cheeks) and SWELLING FACE (swollen cheeks) had resolved. At the time of the report, ANXIETY (anxiety), FLUSHING (flushing) and PRODUCT DOSE OMISSION ISSUE (missed dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) pulse and B. P were elevated. On an unknown date, Electrocardiogram: normal normal (normal) normal. On an unknown date, Heart rate: increased (High) pulse and B. P were elevated.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was received by the patient   Most recent FOLLOW-UP information incorporated above includes: On 01-Aug-2021: significant follow up includes patient other relevant history and events added flushing and anxiety and lab data was added. On 02-Aug-2021: Non-Significant follow up appended On 02-Aug-2021: Non significant follow up patients image was added
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus, Rash, Swelling
Clinical narrative: Rash; Solid red area raised; Solid red area raised and hot; Itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash), SWELLING (Solid red area raised), FEELING HOT (Solid red area raised and hot) and PRURITUS (Itchy) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concomitant products included PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced RASH (Rash), SWELLING (Solid red area raised), FEELING HOT (Solid red area raised and hot) and PRURITUS (Itchy). At the time of the report, RASH (Rash), SWELLING (Solid red area raised), FEELING HOT (Solid red area raised and hot) and PRURITUS (Itchy) outcome was unknown. Not Provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported.   Reporter did not allow further contact
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Warm to the touch; white areas and redness injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (white areas and redness injection site) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (white areas and redness injection site). At the time of the report, VACCINATION SITE WARMTH (Warm to the touch) and VACCINATION SITE ERYTHEMA (white areas and redness injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Body ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (Body ache) and PYREXIA (Fever) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (Body ache) and PYREXIA (Fever). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (Body ache) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Burning feeling at injection site; Itchy feeling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Burning feeling at injection site) and VACCINATION SITE PRURITUS (Itchy feeling at injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included THIOTHIXENE [TIOTIXENE], MIRTAZAPINE and ESTRADIOL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Burning feeling at injection site) and VACCINATION SITE PRURITUS (Itchy feeling at injection site). The patient was treated with ALCOHOL at an unspecified dose and frequency; Hydrogen Peroxide at an unspecified dose and frequency and ICE PACKS at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Burning feeling at injection site) and VACCINATION SITE PRURITUS (Itchy feeling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Flushing, Heart rate increased, Tremor
Clinical narrative: felt off and weak; Flushed; heart rate went up; whole body started shaking; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushed), HEART RATE INCREASED (heart rate went up), TREMOR (whole body started shaking) and ASTHENIA (felt off and weak) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FLUSHING (Flushed), HEART RATE INCREASED (heart rate went up) and TREMOR (whole body started shaking). On 15-Jan-2021, the patient experienced ASTHENIA (felt off and weak). On 14-Jan-2021, FLUSHING (Flushed), HEART RATE INCREASED (heart rate went up) and TREMOR (whole body started shaking) had resolved. On 15-Jan-2021, ASTHENIA (felt off and weak) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She was not treated any medication, rather she was given some juice.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during breast feeding
Clinical narrative: Breastfeeding; This spontaneous case was reported by a physician assistant (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) in a female patient of an unknown age exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the mother received the product for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the mother received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient was diagnosed with MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding). At the time of the report, MATERNAL EXPOSURE DURING BREAST FEEDING (Breastfeeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nasal congestion, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nasal congestion), CHILLS (Chills), FATIGUE (Severe fatigue), PYREXIA (Fever) and MYALGIA (body aches) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (nasal congestion), CHILLS (Chills), FATIGUE (Severe fatigue), PYREXIA (Fever) and MYALGIA (body aches). At the time of the report, NASAL CONGESTION (nasal congestion), CHILLS (Chills), FATIGUE (Severe fatigue), PYREXIA (Fever) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain
Clinical narrative: Bruise; Pain; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruise) and PAIN (Pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced CONTUSION (Bruise) and PAIN (Pain). At the time of the report, CONTUSION (Bruise) and PAIN (Pain) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 69.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Injection site pain
Clinical narrative: soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (soreness at injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBUPROFEN (ADVIL [IBUPROFEN]) for Muscle soreness.    No medical history was provided by the reporter.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started IBUPROFEN (ADVIL [IBUPROFEN]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced INJECTION SITE PAIN (soreness at injection site). At the time of the report, INJECTION SITE PAIN (soreness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (my arm (inj site) was warm to touch), VACCINATION SITE SWELLING (my arm (inj site) was swollen), VACCINATION SITE ERYTHEMA (my arm (inj site) was bright red) and VACCINATION SITE PRURITUS (my arm (inj site) was itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE WARMTH (my arm (inj site) was warm to touch), VACCINATION SITE SWELLING (my arm (inj site) was swollen), VACCINATION SITE ERYTHEMA (my arm (inj site) was bright red) and VACCINATION SITE PRURITUS (my arm (inj site) was itchy). The patient was treated with IBUPROFEN at an unspecified dose and frequency; DIPHENHYDRAMINE at an unspecified dose and frequency; AMMONIUM CHLORIDE at an unspecified dose and frequency and SODIUM CITRATE at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (my arm (inj site) was warm to touch), VACCINATION SITE SWELLING (my arm (inj site) was swollen), VACCINATION SITE ERYTHEMA (my arm (inj site) was bright red) and VACCINATION SITE PRURITUS (my arm (inj site) was itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: No specific follow-up information recorded.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Injection site erythema, Mobility decreased
Clinical narrative: Injection site turned from red to pink; Painful; Inflamed shoulder; Limited range of motion; A spontaneous report (United States) was received from a consumer concerning a 86-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events inflamed shoulder/arthritis, painful/arthralgia, limited range of motion/mobility decreased, injection site turned from red to pink/injection site erythema.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 02 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 02 FEB 2021 patient experienced inflamed shoulder that is painful, limited range of motion on same day of injection. Site of injection turned red to pink.   Treatment for the event included aspirin and iced it.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), inflamed shoulder/arthritis, painful/arthralgia, limited range of motion/mobility decreased, injection site turned from red to pink/injection site erythema was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: pain in his left hand, pain in his left fingers; pain in his left wrist; A spontaneous report was received from a consumer concerning a 72-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events pain in his left hand and pain in his left fingers/pain in extremity, pain in his left wrist/arthralgia.  The patient's medical history included pneumonia and COVID-19 infection November 2020 (hospitalized for 5 days). Past/current medical conditions include carpal tunnel of left hand (diagnosed 10 to 15 years ago). No relevant concomitant medications were reported.  On 18 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch no: 006M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 18 FEB 2021 patient experienced pain in his left hand, wrist and fingers.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), pain in his left hand, wrist and fingers that is ongoing.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site pain, Myalgia
Clinical narrative: low grade fever; chills; body ache; joint pain; Pain; Recurring headaches; This spontaneous case was reported by a dental hygienist and describes the occurrence of HEADACHE (Recurring headaches), PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache) and ARTHRALGIA (joint pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced HEADACHE (Recurring headaches). On an unknown date, the patient experienced PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and INJECTION SITE PAIN (Pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HEADACHE (Recurring headaches), PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and INJECTION SITE PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: low grade fever; chills; body ache; joint pain; Pain; Recurring headaches; This spontaneous case was reported by a dental hygienist and describes the occurrence of HEADACHE (Recurring headaches), PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache) and ARTHRALGIA (joint pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced HEADACHE (Recurring headaches). On an unknown date, the patient experienced PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and INJECTION SITE PAIN (Pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, HEADACHE (Recurring headaches), PYREXIA (low grade fever), CHILLS (chills), MYALGIA (body ache), ARTHRALGIA (joint pain) and INJECTION SITE PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her right arm) and HYPOAESTHESIA (Numbness on right side of body) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013620A) for COVID-19 vaccination.     Concurrent medical conditions included Kidney transplant (The patient has a history of kidney transplant).    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her right arm) and HYPOAESTHESIA (Numbness on right side of body). At the time of the report, PAIN IN EXTREMITY (Soreness in her right arm) and HYPOAESTHESIA (Numbness on right side of body) outcome was unknown.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever ranging 99F-102F; This spontaneous case was reported by a consumer and describes the occurrence of   in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal congestion
Clinical narrative: nasal congestion; Fatigue; tired; A spontaneous report was received from a consumer concerning herself, a female patient of 69-years-old who received Moderna (mRNA-1273) vaccine and experienced tiredness, fatigue and nasal congestion.  The patient's medical history was not provided. No relevant concomitant medications was reported.  The patient received their first of two planned doses of mRNA-1273 (Batch no: unknown) on 18-FEB-2021 intramuscularly in an unspecified site for the prophylaxis of COVID-19 infection.  On 19-FEB-2021, the patient experienced feeling of tired, fatigue and nasal congestion.  Laboratory details was not provided. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the events, tiredness, fatigue, nasal congestion was not recovered/ resolved.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Headache
Clinical narrative: back pain; headache; Case reference number MOD-2021-017271 is a spontaneous case report sent by a Non-Health Professional on 19-FEB-2021 00:00:00 , which refers to a Female aged 90 Years The following drugs are known to have been taken by the patient prior to the event: ASPIRIN (E.C.)[]  .  The patient was administered the second dose of Moderna COVID-19 Vaccine for COVID-19 immunization on 18Feb2021. Some  29 days later,  the patient developed back pain. Since the administration, the patient experienced back pain and headache. The eventual diagnosis made on was Back pain.  The patient was treated for the event with Tylenol and heating pad.   The medical reviewer may provide a case evaluation statement, including other possible etiological and confounding factors, e.g. (only limited information has been obtained so far, it is difficult to assess the cause and effect relationship  Follow-up required.  .   Terse Narrative (for narratives and signal review) Brief 3 line summary of above for listing: Report Source- Non-Health Professional,  Age- 90 Years,  Sex- Female,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome- back pain - Unknown,headache - Unknown.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fibromyalgia, Pain in extremity
Clinical narrative: Diagnosed with Fibromyalgia; Arm was achy; Shoulder was achy; A spontaneous report was received from a consumer concerning a 84-year-old male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced shoulder ache/arthralgia, arm ache/pain in extremity and fibromyalgia..   The patient's medical history, was not provided by the reporter. No concomitant medications reported.   On 19 Jan 2021 prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient experienced shoulder and arm ache. The patient states that he was diagnosed with fibromyalgia.  Treatment for the events were not reported.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, shoulder and arm ache  and fibromyalgia were unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Headache, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), ABDOMINAL PAIN (intestinal discomfort) and HEADACHE (headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), ABDOMINAL PAIN (intestinal discomfort) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), ABDOMINAL PAIN (intestinal discomfort) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-016906 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-016906:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Paraesthesia, Paraesthesia oral, Pruritus
Clinical narrative: Tingling in the face and lips; Tingling face; itching face and arm(not at the injection site); a little fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling in the face and lips), PARAESTHESIA (Tingling face), PRURITUS (itching face and arm(not at the injection site)) and HEART RATE INCREASED (a little fast heart beat) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concomitant products included SECUKINUMAB (COSENTYX) for Psoriatic arthritis, METOPROLOL for Sinus tachycardia.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PARAESTHESIA ORAL (Tingling in the face and lips), PARAESTHESIA (Tingling face), PRURITUS (itching face and arm(not at the injection site)) and HEART RATE INCREASED (a little fast heart beat). At the time of the report, PARAESTHESIA ORAL (Tingling in the face and lips), PARAESTHESIA (Tingling face), PRURITUS (itching face and arm(not at the injection site)) and HEART RATE INCREASED (a little fast heart beat) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: fatigue; swelling at the injection site; injection site soreness; Injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (injection site soreness) and VACCINATION SITE ERYTHEMA (Injection site redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Jan-2021 at 9:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced FATIGUE (fatigue), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (injection site soreness) and VACCINATION SITE ERYTHEMA (Injection site redness). On 26-Jan-2021, FATIGUE (fatigue), VACCINATION SITE SWELLING (swelling at the injection site), VACCINATION SITE PAIN (injection site soreness) and VACCINATION SITE ERYTHEMA (Injection site redness) had resolved. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: The injection site swollen; The injection site red; Raised up below the injection site; Soreness in arm/more tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in arm/more tender), VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 043620A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No prior medical history reported.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), VITAMIN C [ASCORBIC ACID], CALCIUM and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021 at 5:00 PM, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness in arm/more tender). On 27-Jan-2021, the patient experienced VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness in arm/more tender), VACCINATION SITE SWELLING (The injection site swollen), VACCINATION SITE ERYTHEMA (The injection site red) and VACCINATION SITE INDURATION (Raised up below the injection site) had not resolved. Not provided.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest discomfort, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), FATIGUE (LITTLE TIRED), HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache) and OROPHARYNGEAL PAIN (Sore throat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Arthritis. Concomitant products included arthritis medications for Arthritis, high blood pressure medications for Hypertension, BROMAZEPAM (LEXOTAN) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm) and FATIGUE (LITTLE TIRED). On 20-Jan-2021, the patient experienced HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion). On 15-Jan-2021, VACCINATION SITE PAIN (Sore arm) had resolved. On 25-Jan-2021, HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion) had resolved. At the time of the report, FATIGUE (LITTLE TIRED) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), FATIGUE (LITTLE TIRED), HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache) and OROPHARYNGEAL PAIN (Sore throat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Arthritis. Concomitant products included arthritis medications for Arthritis, high blood pressure medications for Hypertension, BROMAZEPAM (LEXOTAN) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm) and FATIGUE (LITTLE TIRED). On 20-Jan-2021, the patient experienced HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion). On 15-Jan-2021, VACCINATION SITE PAIN (Sore arm) had resolved. On 25-Jan-2021, HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion) had resolved. At the time of the report, FATIGUE (LITTLE TIRED) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.